[Correspondence] Efficacy and safety of cannabinoids – Authors’ reply | ClinicLens
We thank Albert Batalla and colleagues and Jing Yuan and colleagues for their comments on our Article.1 As noted, clinical trial data are limited in the generalisability of findings, because the administration of medicinal cannabis in controlled laboratory settings differs to how
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.